1
|
Kirchheiner K, Zaharie AT, Smet S, Spampinato S, Chargari C, Mahantshetty UM, Segedin B, Bruheim K, Rai B, Cooper R, Van der Steen-Banasik E, Wiebe EM, Potter R, Kirisits C, Schmid M, Haie-Meder C, Tanderup K, De Leeuw A, Jurgenliemk-Schulz I, Nout RA. Association between Regular Vaginal Dilation and/or Sexual Activity and Long-Term Vaginal Morbidity in Cervical Cancer Survivors. Int J Radiat Oncol Biol Phys 2023; 117:S2-S3. [PMID: 37784450 DOI: 10.1016/j.ijrobp.2023.06.207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) To evaluate the association between regular vaginal dilation and/or sexual activity and vaginal morbidity in locally advanced cervical cancer patients after definitive radiochemotherapy and image-guided adaptive brachytherapy from the EMBRACE I study. MATERIALS/METHODS Physician-assessed vaginal morbidity (CTCAE v.3), vaginal dilation and patient-reported sexual activity (EORTC QLQ CX24) were assessed at baseline, every 3 months in the 1st year, every 6 months in the 2nd and 3rd year and yearly thereafter. For this longitudinal analysis, a subgroup of patients was selected with at least 3 follow-ups with information on vaginal dilation and/or sexual activity. Vaginal penetration summarized either the use of vaginal dilators or sexual activity or both. Regular vaginal penetration was defined if reported in ≥50%, infrequent if reported in <50% and absent if reported in 0% of follow-ups. Actuarial estimates of vaginal morbidity were calculated with Kaplan-Meier method and included the individual symptoms: vaginal dryness, stenosis, mucositis and bleeding. Group comparisons were evaluated with the log-rank test. RESULTS The EMBRACE I study included 1416 patients overall (2008-2015); the subgroup of patients for this longitudinal evaluation consists of 882 patients, with a median follow-up of 60 months (IQR 47-77). Of those, 565 (64%) reported regular, 205 (23%) infrequent and 112 (13%) no penetration. Reporting regular penetration was associated with a significantly lower risk of vaginal stenosis G≥2 of 23% at 5 years, compared to reporting of infrequent (37%) and no penetration (36%, p≤0.001). However, reporting regular penetration was associated with a significantly higher risk for vaginal dryness G≥1 (72% vs. 69% vs. 62%, respectively, p = 0.038) and bleeding G≥1 (61% vs. 40% vs. 25%, respectively, p≤0.001). No associations were seen for G≥1 vaginal stenosis, G≥2 dryness, G≥2 bleeding and G≥1/G≥2 mucositis. CONCLUSION Regular penetration (defined as vaginal dilation and/or sexual activity) was associated with lower risk for vaginal stenosis G≥2, but higher risk for vaginal dryness G≥1 and bleeding G≥1. Mild vaginal dryness seems to become apparent in particular for patients experiencing vaginal penetration. Minor vaginal blood loss during dilation and/or sexual activity is commonly reported by patients, resulting from atrophy of the vaginal mucosa and/or telangiectasia. While both of these G≥1 symptoms can be managed with lubricants, moisturizer and/or hormonal replacement therapy, G≥2 vaginal stenosis represents an irreversible fibrotic adverse event that can cause dyspareunia in many cancer patients. These long-term data support clinical recommendations for dilation and/or sexual activity after radiotherapy.
Collapse
Affiliation(s)
- K Kirchheiner
- Department Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Vienna, Austria
| | - A T Zaharie
- Department Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Vienna, Austria
| | - S Smet
- Department of Radiation Oncology, AZ Turnhout, Iridium Cancer Network, Antwerp, Turnhout, Belgium
| | - S Spampinato
- Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
| | - C Chargari
- Department of Radiotherapy, Gustave-Roussy, Villejuif, Villejuif, France
| | - U M Mahantshetty
- Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai & Homi Bhabha Cancer Hospital & Research Centre, Visakhapatnam, India
| | - B Segedin
- Department of Radiotherapy and Faculty of Medicine, Institute of Oncology Ljubljana and University of Ljubljana, Ljubljana, Slovenia
| | - K Bruheim
- Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
| | - B Rai
- Department of Radiotherapy and Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
| | - R Cooper
- Leeds Cancer Centre, St James's University Hospital, Leeds, United Kingdom
| | | | - E M Wiebe
- Department of Oncology, Cross Cancer Institute and University of Alberta, Edmonton, AB, Canada
| | - R Potter
- Department for Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
| | - C Kirisits
- Department for Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
| | - M Schmid
- Department Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
| | - C Haie-Meder
- Department of Radiotherapy, Gustave-Roussy, Villejuif, Villejuif, France
| | - K Tanderup
- Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
| | - A De Leeuw
- Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands
| | - I Jurgenliemk-Schulz
- Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands
| | - R A Nout
- Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
| |
Collapse
|
2
|
Spampinato S, Tanderup K, Nout R, Smet S, Lindegaard J, Fokdal L, Pötter R, Sturdza A, Segedin B, Jürgenliemk-Schulz I, Bruheim K, Mahantshetty U, Chargari C, Rai B, Cooper R, van der Steen-Banasik E, Sundset M, Wiebe E, Villafranca E, Van Limbergen E, Chopra S, Kirchheiner K. OC-0588 Impact of persistent symptoms on long-term quality of life of cervical cancer survivors in EMBRACE I. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02610-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
3
|
Beeckman D, Fourie A, Raepsaet C, Van Damme N, Manderlier B, De Meyer D, Beele H, Smet S, Demarré L, Vossaert R, de Graaf A, Verhaeghe L, Vandergheynst N, Hendrickx B, Hanssens V, Keymeulen H, Vanderwee K, Van De Woestijne J, Verhaeghe S, Van Hecke A, Savoye I, Harrison J, Vrijens F, Hulstaert F. Silicone adhesive multilayer foam dressings as adjuvant prophylactic therapy to prevent hospital-acquired pressure ulcers: a pragmatic noncommercial multicentre randomized open-label parallel-group medical device trial. Br J Dermatol 2020; 185:52-61. [PMID: 33216969 PMCID: PMC8359283 DOI: 10.1111/bjd.19689] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/17/2020] [Indexed: 12/14/2022]
Abstract
Background Silicone adhesive multilayer foam dressings are used as adjuvant therapy to prevent hospital‐acquired pressure ulcers (PUs). Objectives To determine whether silicone foam dressings in addition to standard prevention reduce the incidence of PUs of category 2 or worse compared with standard prevention alone. Methods This was a multicentre, randomized controlled medical device trial conducted in eight Belgian hospitals. At‐risk adult patients were centrally randomized (n = 1633) to study groups based on a 1 : 1 : 1 allocation: experimental groups 1 (n = 542) and 2 (n = 545) – pooled as the treatment group – and the control group (n = 546). The experimental groups received PU prevention according to hospital protocol, and a silicone foam dressing on the relevant body sites. The control group received standard of care. The primary endpoint was the incidence of a new PU of category 2 or worse at the studied body sites. Results In the intention‐to‐treat population (n = 1605), PUs of category 2 or worse occurred in 4·0% of patients in the treatment group and 6·3% in the control group [relative risk (RR) 0·64, 95% confidence interval (CI) 0·41–0·99, P = 0·04]. Sacral PUs were observed in 2·8% and 4·8% of the patients in the treatment group and the control group, respectively (RR 0·59, 95% CI 0·35–0·98, P = 0·04). Heel PUs occurred in 1·4% and 1·9% of patients in the treatment and control groups, respectively (RR 0·76, 95% CI 0·34–1·68, P = 0·49). Conclusions Silicone foam dressings reduce the incidence of PUs of category 2 or worse in hospitalized at‐risk patients when used in addition to standard of care. The results show a decrease for the sacrum, but no statistical difference for the heel and trochanter areas. What is already known about this topic?The incidence of hospital‐acquired pressure ulcers (PUs) remains high despite the implementation of best‐practice recommendations. The concept of using silicone foam dressings as an additional prophylactic strategy in PU prevention has been investigated in previous studies but with some limitations. Most RCTs were monocentric studies, restricted to either critically ill or acute care patients and did not observe more than two anatomical at‐risk skin sites, which limited the generalizability of the findings.
What does this study add?This large pragmatic RCT suggests that it is beneficial to use silicone adhesive multilayer foam dressings on the sacrum, in addition to standard of care, to help prevent hospital‐acquired PUs. Clinical decision making for heel dressings should be based on the clinical effectiveness of the intervention weighed against the potential risk of falling.
Linked Comment: F. Coyer. Br J Dermatol 2021; 185:4–5.
Collapse
Affiliation(s)
- D Beeckman
- Skin Integrity Research Group (SKINT), University Centre for Nursing and Midwifery, Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.,School of Nursing & Midwifery, Royal College of Surgeons in Ireland, Dublin, Ireland.,School of Health Sciences, Örebro University, Örebro, Sweden
| | - A Fourie
- Skin Integrity Research Group (SKINT), University Centre for Nursing and Midwifery, Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
| | - C Raepsaet
- Skin Integrity Research Group (SKINT), University Centre for Nursing and Midwifery, Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
| | - N Van Damme
- Skin Integrity Research Group (SKINT), University Centre for Nursing and Midwifery, Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
| | - B Manderlier
- Skin Integrity Research Group (SKINT), University Centre for Nursing and Midwifery, Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
| | - D De Meyer
- Skin Integrity Research Group (SKINT), University Centre for Nursing and Midwifery, Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
| | - H Beele
- Wound Care Centre, Ghent University, Ghent, Belgium
| | - S Smet
- Wound Care Centre, Ghent University, Ghent, Belgium
| | - L Demarré
- AZ Sint-Elisabeth, Zottegem, Oost-Vlaanderan, Belgium
| | - R Vossaert
- AZ Sint-Elisabeth, Zottegem, Oost-Vlaanderan, Belgium
| | - A de Graaf
- Wound Care Support Team, Nursing Centre of Excellence, University Hospitals of Leuven, Leuven, Belgium
| | | | | | - B Hendrickx
- University Hospital of Brussels (UZB), Department of Plastic Surgery, Brussels, Belgium
| | - V Hanssens
- University Hospital of Brussels (UZB), Department of Plastic Surgery, Brussels, Belgium
| | - H Keymeulen
- OLV Ziekenhuis Aalst, Aalst, Oost-Vlaanderan, Belgium
| | - K Vanderwee
- OLV van Lourdes Ziekenhuis Waregem, Waregem, West-Vlaanderan, Belgium
| | | | - S Verhaeghe
- Skin Integrity Research Group (SKINT), University Centre for Nursing and Midwifery, Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
| | - A Van Hecke
- Skin Integrity Research Group (SKINT), University Centre for Nursing and Midwifery, Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
| | - I Savoye
- Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium
| | - J Harrison
- Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium
| | - F Vrijens
- Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium
| | - F Hulstaert
- Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium
| |
Collapse
|
4
|
Smet S, Tanderup K, Nout R, Jürgenliemk-Schulz I, Spampinato S, Chargari C, Lindegaard J, Mahantshetty U, Strudza A, Schmid M, Hoskin P, Segedin B, Bruheim K, Rai B, Huang F, Van Der Steen-Basanik E, Cooper R, Van Limbergen E, Sundset M, Pötter R, Kirchheiner K. OC-0317: Risk factors for persistent late fatigue after radiochemotherapy in cervical cancer (EMBRACE study). Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00341-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
5
|
Van Tiggelen H, LeBlanc K, Campbell K, Woo K, Baranoski S, Chang Y, Dunk A, Gloeckner M, Hevia H, Holloway S, Idensohn P, Karadağ A, Koren E, Kottner J, Langemo D, Ousey K, Pokorná A, Romanelli M, Santos V, Smet S, Tariq G, Van den Bussche K, Van Hecke A, Verhaeghe S, Vuagnat H, Williams A, Beeckman D. Standardizing the classification of skin tears: validity and reliability testing of the International Skin Tear Advisory Panel Classification System in 44 countries. Br J Dermatol 2020; 183:146-154. [PMID: 31605618 PMCID: PMC7384145 DOI: 10.1111/bjd.18604] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/06/2019] [Indexed: 01/21/2023]
Abstract
BACKGROUND Skin tears are acute wounds that are frequently misdiagnosed and under-reported. A standardized and globally adopted skin tear classification system with supporting evidence for diagnostic validity and reliability is required to allow assessment and reporting in a consistent way. OBJECTIVES To measure the validity and reliability of the International Skin Tear Advisory Panel (ISTAP) Classification System internationally. METHODS A multicountry study was set up to validate the content of the ISTAP Classification System through expert consultation in a two-round Delphi procedure involving 17 experts from 11 countries. An online survey including 24 skin tear photographs was conducted in a convenience sample of 1601 healthcare professionals from 44 countries to measure diagnostic accuracy, agreement, inter-rater reliability and intrarater reliability of the instrument. RESULTS A definition for the concept of a 'skin flap' in the area of skin tears was developed and added to the initial ISTAP Classification System consisting of three skin tear types. The overall agreement with the reference standard was 0·79 [95% confidence interval (CI) 0·79-0·80] and sensitivity ranged from 0·74 (95% CI 0·73-0·75) to 0·88 (95% CI 0·87-0·88). The inter-rater reliability was 0·57 (95% CI 0·57-0·57). The Cohen's Kappa measuring intrarater reliability was 0·74 (95% CI 0·73-0·75). CONCLUSIONS The ISTAP Classification System is supported by evidence for validity and reliability. The ISTAP Classification System should be used for systematic assessment and reporting of skin tears in clinical practice and research globally. What's already known about this topic? Skin tears are common acute wounds that are misdiagnosed and under-reported too often. A skin tear classification system is needed to standardize documentation and description for clinical practice, audit and research. What does this study add? The International Skin Tear Advisory Panel Classification System was psychometrically tested in 1601 healthcare professionals from 44 countries. Diagnostic accuracy was high when differentiating between type 1, 2 and 3 skin tears using a set of validated photographs.
Collapse
|
6
|
Beeckman D, Van den Bussche K, Alves P, Arnold Long M, Beele H, Ciprandi G, Coyer F, de Groot T, De Meyer D, Deschepper E, Dunk A, Fourie A, García-Molina P, Gray M, Iblasi A, Jelnes R, Johansen E, Karadağ A, Leblanc K, Kis Dadara Z, Meaume S, Pokorna A, Romanelli M, Ruppert S, Schoonhoven L, Smet S, Smith C, Steininger A, Stockmayr M, Van Damme N, Voegeli D, Van Hecke A, Verhaeghe S, Woo K, Kottner J. Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries. Br J Dermatol 2018. [DOI: 10.1111/bjd.16754] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Beeckman D, Van den Bussche K, Alves P, Arnold Long M, Beelev H, Ciprandi G, Coyer F, de Groot T, De Meyer D, Deschepper E, Dunk A, Fourie A, García-Molina P, Gray M, Iblasi A, Jelnes R, Johansen E, Karadag A, Leblanc K, Kis Dadara Z, Meaume S, Pokorna A, Romanelli M, Ruppert S, Schoonhoven L, Smet S, Smith C, Steininger A, Stockmayr M, Van Damme N, Voegeli D, Van Hecke A, Verhaeghe S, Woo K, Kottner J. 建立失禁相关性皮炎(IAD)相关国际通用术语:在30个国家/地区进行根特全球(IAD)分类工具(GLOBIAD)心理测量特性的设计和评估. Br J Dermatol 2018. [DOI: 10.1111/bjd.16766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
8
|
Beeckman D, Van den Bussche K, Alves P, Arnold Long MC, Beele H, Ciprandi G, Coyer F, de Groot T, De Meyer D, Deschepper E, Dunk AM, Fourie A, García-Molina P, Gray M, Iblasi A, Jelnes R, Johansen E, Karadağ A, Leblanc K, Kis Dadara Z, Meaume S, Pokorna A, Romanelli M, Ruppert S, Schoonhoven L, Smet S, Smith C, Steininger A, Stockmayr M, Van Damme N, Voegeli D, Van Hecke A, Verhaeghe S, Woo K, Kottner J. Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries. Br J Dermatol 2018; 178:1331-1340. [PMID: 29315488 DOI: 10.1111/bjd.16327] [Citation(s) in RCA: 39] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/01/2018] [Indexed: 11/27/2022]
Abstract
BACKGROUND Incontinence-associated dermatitis (IAD) is a specific type of irritant contact dermatitis with different severity levels. An internationally accepted instrument to assess the severity of IAD in adults, with established diagnostic accuracy, agreement and reliability, is needed to support clinical practice and research. OBJECTIVES To design the Ghent Global IAD Categorization Tool (GLOBIAD) and evaluate its psychometric properties. METHODS The design was based on expert consultation using a three-round Delphi procedure with 34 experts from 13 countries. The instrument was tested using IAD photographs, which reflected different severity levels, in a sample of 823 healthcare professionals from 30 countries. Measures for diagnostic accuracy (sensitivity and specificity), agreement, interrater reliability (multirater Fleiss kappa) and intrarater reliability (Cohen's kappa) were assessed. RESULTS The GLOBIAD consists of two categories based on the presence of persistent redness (category 1) and skin loss (category 2), both of which are subdivided based on the presence of clinical signs of infection. The agreement for differentiating between category 1 and category 2 was 0·86 [95% confidence interval (CI) 0·86-0·87], with a sensitivity of 90% and a specificity of 84%. The overall agreement was 0·55 (95% CI 0·55-0·56). The Fleiss kappa for differentiating between category 1 and category 2 was 0·65 (95% CI 0·65-0·65). The overall Fleiss kappa was 0·41 (95% CI 0·41-0·41). The Cohen's kappa for differentiating between category 1 and category 2 was 0·76 (95% CI 0·75-0·77). The overall Cohen's kappa was 0·61 (95% CI 0·59-0·62). CONCLUSIONS The development of the GLOBIAD is a major step towards a better systematic assessment of IAD in clinical practice and research worldwide. However, further validation is needed.
Collapse
Affiliation(s)
- D Beeckman
- University Centre for Nursing and Midwifery, Department of Public Health, Ghent University, Ghent, Belgium.,School of Nursing and Midwifery, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - K Van den Bussche
- University Centre for Nursing and Midwifery, Department of Public Health, Ghent University, Ghent, Belgium
| | - P Alves
- Centre for Interdisciplinary Research in Health, Institute of Health Sciences, Catholic University of Portugal, Oporto, Portugal
| | - M C Arnold Long
- Department of Nursing, Roper Hospital, Charleston, SC, U.S.A
| | - H Beele
- Department of Dermatology, Ghent University Hospital, Ghent, Belgium
| | - G Ciprandi
- Department of Pediatric Surgery, Division of Plastic and Maxillofacial Surgery, Bambino Gesu' Children's Hospital, Research Institute, Rome, Italy
| | - F Coyer
- Intensive Care Services, Royal Brisbane and Women's Hospital and School of Nursing, Queensland University of Technology, Brisbane, Australia
| | - T de Groot
- Wond Expertise Centrum, Lange Land Ziekenhuis, Zoetermeer, the Netherlands
| | - D De Meyer
- University Centre for Nursing and Midwifery, Department of Public Health, Ghent University, Ghent, Belgium
| | - E Deschepper
- University Centre for Nursing and Midwifery, Department of Public Health, Ghent University, Ghent, Belgium
| | - A M Dunk
- Tissue Viability Unit, Canberra Hospital, ACT Health, Canberra, Australia
| | - A Fourie
- Scientific Affairs & Education Manager, 3M (Critical and Chronic Care Solutions), Johannesburg, South Africa
| | - P García-Molina
- Department of Nursing, University of Valencia, Valencia, Spain
| | - M Gray
- Department of Urology, University of Virginia, Charlottesville, VA, U.S.A
| | - A Iblasi
- Wound Care, King Saud Medical City (KSMC), Riyadh, Saudi Arabia
| | - R Jelnes
- Wound Clinic, Sygehus Sonderjylland, Sonderborg, Denmark
| | - E Johansen
- University College of Southeast Norway, Department of Nursing and Health Sciences, Faculty of Health and Social Sciences, Drammen, Norway
| | - A Karadağ
- School of Nursing, Koc University, Istanbul, Turkey
| | - K Leblanc
- School of Nursing, Faculty of Health Sciences, Queen's University, Kingston, Canada
| | - Z Kis Dadara
- Development of Care, Barmherzige Brüder Austria, Vienna, Austria
| | - S Meaume
- Geriatric and Wound Healing Department, APHP, Hôpital Rothschild, Paris, France
| | - A Pokorna
- Department of Nursing, Masaryk University, Faculty of Medicine, Brno, Czech Republic
| | - M Romanelli
- Department of Dermatology, University of Pisa, Pisa, Italy
| | - S Ruppert
- Department of Medicine II, Vienna General Hospital, Vienna, Austria
| | - L Schoonhoven
- Faculty of Health Sciences, University of Southampton, Southampton, U.K.,National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC Wessex), University of Southampton, Southampton, U.K.,Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Institute for Quality of Healthcare, Nijmegen, the Netherlands
| | - S Smet
- Wound Care Center, Ghent University Hospital, Ghent, Belgium
| | - C Smith
- Wound Ostomy Clinic, Marion General Hospital, Marion, IN, U.S.A
| | - A Steininger
- Private Universität für Medizinische Informatik und Technik (UMIT) und Pflegeakademie der Barmherzigen Brüder Wien Pflegewissenschaft und Gerontologie, Vienna, Austria
| | - M Stockmayr
- Department of Surgery, Vienna General Hospital, Vienna, Austria
| | - N Van Damme
- University Centre for Nursing and Midwifery, Department of Public Health, Ghent University, Ghent, Belgium
| | - D Voegeli
- Faculty of Health Sciences, University of Southampton, Southampton, U.K
| | - A Van Hecke
- University Centre for Nursing and Midwifery, Department of Public Health, Ghent University, Ghent, Belgium
| | - S Verhaeghe
- University Centre for Nursing and Midwifery, Department of Public Health, Ghent University, Ghent, Belgium
| | - K Woo
- Department of Nursing, Queen's University, Kingston, Canada
| | - J Kottner
- University Centre for Nursing and Midwifery, Department of Public Health, Ghent University, Ghent, Belgium.,Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universtitätsmedizin Berlin, Berlin, Germany
| |
Collapse
|
9
|
Smet S, Nesvacil N, Knoth J, Sturdza A, Najjari-Jamal D, Jelinek F, Kronreif G, Pötter R, Widder J, Kirisits C, Schmid M. PO-1016: TRUS/CT for IGABT in cervical cancer: an interobserver study on target volume contouring. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31326-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
De Blay F, Radu C, Choual I, Khayath N, Jilani S, Beck N, Smet S, Domis N. Validation clinique de la chambre d’exposition environnementale de Strasbourg (ALYATEC ® ) chez des patients asthmatiques allergiques aux acariens. Rev Mal Respir 2018. [DOI: 10.1016/j.rmr.2017.10.134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
11
|
Smet S, Najjari-Jamal D, Bk Jensen N, Fokdal L, Lindegaard J, Kirisits C, Haie-Meder C, Mahantshetty U, Jürgenliemk-Schulz I, Van Limbergen E, Segedin B, Hoskin P, Tanderup K, Pötter R, Kirchheiner K. OC-0051: Fatigue, insomnia, hot flashes (CTCAE) after definitive RCHT+IGABT for cervical cancer (EMBRACE). Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30495-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
12
|
Najjari Jamal D, Smet S, Bk Jensen N, Fokdal L, Lindegaard J, Kirisits C, Chargari C, Mahantshetty U, Jügenliemk-Schulz I, Segedin B, Hoskin P, Tanderup K, Pötter R, Kirchheiner K. OC-0053: Physician assessed and patient reported limb edema after RCHT + IGABT for cervical cancer (EMBRACE). Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30497-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
13
|
Gijzen A, Smet S. Seventy years Okapi. Okapi Johnstoni (Sclater, 1901). Acta Zool Pathol Antverp 1974:3-111. [PMID: 4440605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|